Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human β3 adrenergic receptor agonists
- 16 October 2000
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 10 (20) , 2283-2286
- https://doi.org/10.1016/s0960-894x(00)00459-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Synthesis and Human β-Adrenoceptor Activity of 1-(3,5-Diiodo-4- methoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-6-ol Derivatives in VitroJournal of Medicinal Chemistry, 2000
- 2-Amino-4-benzyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridines: Novel Selective β3-Adrenoceptor AgonistsJournal of Medicinal Chemistry, 1999
- 3-pyridylethanolamines: Potent and selective human β3 adrenergic receptor agonistsBioorganic & Medicinal Chemistry Letters, 1998
- Discovery of L-755,507: A subnanomolar human β3 adrenergic receptor agonistBioorganic & Medicinal Chemistry Letters, 1998
- β3 Adrenergic Receptor Agonists for the Treatment of ObesityPublished by Elsevier ,1998
- β3-adrenergic agonists: potential therapeutics for obesityExpert Opinion on Investigational Drugs, 1997
- BROWN ADIPOSE TISSUE, β3-ADRENERGIC RECEPTORS, AND OBESITYAnnual Review of Medicine, 1997
- New publicationsPsychiatric Bulletin, 1996
- Cardiac effects of the beta 3‐adrenoceptor agonist BRL35135 in man.British Journal of Clinical Pharmacology, 1994
- Weight loss in obese subjects on a restricted diet given BRL 26830A, a new atypical adrenoceptor agonistBMJ, 1988